Minocycline treatment for chronic autoimmune uveitis
Official title: The Efficacy and Safety of Minocycline for Chronic Autoimmune Uveitis
Run by Sun Yat-sen University · NCT05474729 · Data updated 2026-11-12
This study is testing if minocycline can help people aged 18-60 with chronic autoimmune uveitis reduce inflammation and protect their vision better than current treatments.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | Sun Yat-sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | December 1, 2021 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | April 18, 2023 |
| Trial ID | NCT05474729 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-60 diagnosed with autoimmune diseases that have caused visual function damage.
✕Probably not a fit
Patients who are allergic to minocycline or currently using glucocorticoids, immunosuppressants, or biologics may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the efficacy and safety of minocycline in patients suffering from chronic autoimmune uveitis, a severe ocular disease that can lead to blindness. The study aims to address the limitations of current treatments, such as glucocorticoids and immunosuppressants, which often show inadequate results. Participants will receive minocycline to evaluate its potential benefits in reducing inflammation and preserving visual function. The trial is designed for individuals aged 18-60 who have experienced visual impairment due to autoimmune conditions.
Why it matters
Potential benefit: If successful, this treatment could significantly improve visual outcomes and quality of life for patients with chronic autoimmune uveitis.
How similar studies have gone: While minocycline has shown promise in other neuro-inflammatory diseases, its application in chronic autoimmune uveitis is relatively novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant diagnosed of autoimmune diseases with visual function damage (decrease of BCVA, loss of retinal structure) * Participant aged from 18-60 years old. * Participant that signed the informed consent document and is able to complete the following visits. Exclusion Criteria: * Participant is allergy to minocycline or tetracyclines. * Participant has no contraindications of minocycline or tetracyclines. * Participant has an abnormal function of liver, heart, kidney and thyroid. * Participant is using glucocorticoids, immunosuppressants or biologics. * Female that is pregnant, breast-feeding or planning to become pregnant. * Participant that is currently using other medications for other diseases.
Where it's running
-
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, China Recruiting
Study contacts
- Principal investigator: Dan Liang — Zhongshan Ophthalmic Center, Sun Yat-sen University
- Study coordinator: Dan Liang
- Email: liangdan@gzzoc.com
- Phone: （86）-87330402
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ocular Fluid Work-up in Presumed Trematode-Induced Granulomatous Uveitis
This study tests ocular fluid samples from patients with presumed trematode-induced granulomatous uveitis who are having eye surgery to look for clues about the cause.
-
PANDA-ASOCT: Detecting Uveitis in Children with Automated Eye Image Analysis
This study tests a high-speed, non-invasive eye imaging system with automated analysis to help detect uveitis in children and young people who attend a clinic for uveitis or juvenile idiopathic arthritis.
-
Minocycline after successful recanalization in acute anterior circulation stroke
This trial tests whether adding minocycline after a successful endovascular thrombectomy helps people recover better after an acute anterior circulation stroke.
-
Minocycline after successful reopening of posterior circulation stroke with endovascular therapy
This trial tests whether adding minocycline after successful thrombectomy helps people recover better from a posterior circulation stroke.
-
GenSci048 vs placebo in active non-infectious uveitis
This study tests whether GenSci048 can help people with active non-infectious uveitis compared with placebo.
-
Uveitis in children under 18
This project collects medical information from children with uveitis to see how often different types occur and what treatments and clinical features look like.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.